Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Oncogene|April 5, 2023
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilitiesIrene Paassen, Justin Williams, Carla Ríos Arceo, et al.Molecular Cancer Therapeutics|May 27, 2020
A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in <i>BRAF</i>-Driven Pediatric Low-Grade Glioma CellsDiren Usta, Romain Sigaud, Juliane L Buhl, et al.Cancer Immunology Research|June 14, 2024
Knocking Out CD70 Rescues CD70-Specific NanoCAR T Cells from Antigen-Induced ExhaustionStijn De Munter, Juliane L Buhl, Laurenz De Cock, et al.Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.Clinical Epigenetics|December 12, 2019
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemiaCornelis M van Tilburg, Till Milde, Ruth Witt, et al.Neuro-Oncology|July 29, 2025
A cycling, progenitor-like cell population at the base of atypical teratoid rhabdoid tumor subtype differentiation trajectoriesEnrique Blanco-Carmona, Irene Paassen, Jiayou He, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2018
The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic AstrocytomaJuliane L Buhl, Florian Selt, Thomas Hielscher, et al.Journal for Immunotherapy of Cancer|March 22, 2024
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1Annelisa M Cornel, Loutje van der Sman, Jip T van Dinter, et al.Nature Communications|August 5, 2025
Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector functionMarta Barisa, Henrike P Muller, Elisa Zappa, et al.Pageof 1